Acibadem Healthcare Group
Prof. M.D.

Tugan Beşe

Affiliated Hospitals
Book an Appointment Free Second Opinion Verified Acibadem Specialist
Tugan Beşe
Part of the Acibadem Healthcare Network45 HospitalsInternational Patient ServicesJCI Accredited Healthcare System
Clinical Authority

Clinical Focus Areas

About Tugan Beşe, M.D.

Prof. Tugan Beşe is a gynecologic oncology surgeon with board certification in Gynecologic Oncology Surgery (2011). He has been part of the Acıbadem Health Group since 2005, contributing to clinical care, surgical practice, and multidisciplinary oncology teams. He is an active member of the Turkish Society of Gynecologic Oncology and participates in professional education and collaborative research within the field. Education – Board Certification, Gynecologic Oncology Surgery, 2011 Professional Experience – Acıbadem Health Group, Surgeon, 2005–present Professional Memberships – Turkish Society of Gynecologic Oncology M.D. Beşe focuses on delivering evidence-based surgical care for gynecologic cancers and working with colleagues to improve patient outcomes and training in oncologic surgery.

Education

  • 2011 Board of Medical Specialization Gynecologic Oncology Surgery
  • 2002 Istanbul University Cerrahpaşa Faculty of Medicine Professor
  • 1996 Istanbul University Cerrahpaşa Faculty of Medicine Associate Professor
  • 1992 Istanbul University Cerrahpaşa Faculty of Medicine Gynecology and Obstetrics
  • 1986 Ankara University Faculty of Medicine

Experience

  • 2005 Acibadem Health Group
  • 1993 Department of Gynecologic Oncology, Royal Marsden Hospital London, Observer
  • 1992 Department of Obstetrics and Gynecology, Istanbul University Cerrahpaşa Faculty of Medicine
  • 1987 – 1992 Istanbul University Cerrahpaşa Faculty of Medicine, Department of Obstetrics and Gynecology, Residency

Memberships

  • Turkish Society of Gynecologic Oncology

Publications

  • The effect of long-term use of progesterone therapy on proliferation and apoptosis in simple endometrial hyperplasia without atypia.
    Int J Gynecol Cancer 2006, 16,809-813 Beşe T, Vural A, Ozturk M, Dagistanh F, Demirkiran F, Tunctemir M, Arvas M, Sanioglu C, Kosebay D.
  • Skin metastasis in ovarian carcinoma.
    Int J Gynecol Cancer 2006; 16(1): 1-4 Yilmaz Z, Beşe T, Demirkiran F, ilvan S, §aniogIu C, Arvas M, Kosebay D.
  • A case with multiple gynecological malignancies.
    Int J Gynecol Cancer. 2005 Mar-Apr; 15(2):372-6 Goker BO, Bese T. Ilvan S, Yilmaz E, Demirkiran F.
  • The accuracy of frozen section (intraoperative consultation) in the diagnosis of ovarian masses.
    Gynecol Oncol. 2005 May; 97(2):395-9 Ilvan S, Ramazanoglu R, Ulker Akyildiz E, Calay Z, Bese T. Oruc N.
  • Comparison of transvaginal sonography, saline infusion sonography and hysteroscopy in the evaluation of uterine cavity pathologies.
    Aust N Z J Obstet Gynaecol. 2005 Feb;45(l):30-5 13- Cepni I, Ocal P, Erkan S, Saricali FS, Akbas H, Demirkiran F, Idil M, Bese T.
  • Primary fallopian tube carcinoma: a retrospective multicenter study.
    Eur J Gynaecol Oncol. 2004;25(5):611-4 12- Tulunay G, Arvas M, Demir B, Demirkiran F, Boran N, Bese T. Ozgul N, Kose MF, Kosebay D.
  • Hydrosonography in screening for intracavitary pathology in infertile women.
    Int J Gynaecol Obstet. 2004 Sep;86(3):377-83 Guven MA, Beşe T, Demirkiran F, Idil M, Mgoyi L.
International Patient ServicesCoordinated support for patients traveling for care.
Multidisciplinary CareDoctors, hospitals and technologies aligned around the patient pathway.
Premium Healthcare ExperienceA structured, clear and reassuring medical journey.
×
Logo

29 hospitals and 15 medical centers in 5 countries.

About Us
Hospitals
Treatments
Doctors
Medical Technologies
Check Up Packages
Appointment
Blog
Contact
Contact Us
Promotional
About Us

At ACIBADEM Healthcare Group, we are committed to healthcare excellence and providing world-class healthcare services to our patients. As a leader in international healthcare, we strive to deliver the highest quality of care and meet the needs of our diverse patient population.

Read More...